查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1538237

單採市場報告：2030 年趨勢、預測與競爭分析

Apheresis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

單採趨勢和預測

預計到 2030 年，全球單採市場將達到 23 億美元，2024 年至 2030 年複合年成長率為 7.5%。市場的主要促進因素是慢性腎臟病盛行率的上升、政府鼓勵捐血的宣傳活動加大以及對血液成分的需求不斷成長。全球單採市場的未來看起來充滿希望，血液中心和醫院市場充滿機會。

按分段進行血漿分離術

本研究包括按產品類型、方法、程序、最終用途和地區分類的全球單採預測。

單採市場洞察

Lucintel 預計，由於離心在新鮮冰凍血漿和濃縮紅血球等血液成分的製備中被廣泛採用，因此在預測期內離心仍將是最大的細分市場。

在這個市場中，血液中心在預測期內可能仍佔較大佔有率。

由於擴大採用最先進的單採系統以及該地區人口中血液相關疾病的盛行率不斷增加，北美在預測期內仍將是最大的地區。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球單採血液市場預計將達到 23 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球單採市場預計將以7.5%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 這個市場的主要促進因素是慢性腎臟病盛行率的上升、政府鼓勵捐血的宣傳活動不斷增加以及對血液成分的需求不斷成長。

Q4.市場的主要細分市場是：

A4. 單採市場前景廣闊，血液中心和醫院市場充滿機會。

Q5.市場的主要企業是：

A5. 主要的單採公司如下：

  • Kawasumi Laboratories
  • Nikkiso
  • Haemonetics Corporation
  • Asahi Kasei Medical
  • Cerus Corporation
  • Kaneka Corporation
  • Charles River Laboratories International
  • B. Braun Melsungen
  • Fresenius Kabi
  • Terumo BCT

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，由於離心在血液成分（包括新鮮冰凍血漿和濃縮紅血球）的製備中廣泛採用，因此在預測期內離心仍將是最大的部分。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於最先進的單採系統的日益普及以及該地區人口中血液相關疾病的患病率不斷增加，北美在預測期內仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球單採市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球單採市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品類型分類的全球單採市場
    • 一次性用品和試劑
    • 軟體
    • 裝置
  • 按方法分類的全球單採市場
    • 離心
    • 膜分離
    • 選擇性吸附
  • 按程序分類的全球單採市場
    • 供體/自動血漿分離術
    • 治療血漿分離術
  • 以最終用途分類的全球單採市場
    • 血液中心
    • 醫院
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的全球單採市場
  • 北美單採市場
  • 歐洲單採市場
  • 亞太地區單採市場
  • 其他地區單採市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球單採市場成長機會
    • 按方法分類的全球單採市場成長機會
    • 按程序分類的全球單採市場成長機會
    • 按最終用途分類的全球單採市場成長機會
    • 按地區分類的全球單採市場成長機會
  • 全球單採市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球單採市場的產能
    • 全球單採市場的合併、收購及合資企業
    • 認證和許可

第7章主要企業概況

  • Kawasumi Laboratories
  • Nikkiso
  • Haemonetics Corporation
  • Asahi Kasei Medical
  • Cerus Corporation
  • Kaneka Corporation
  • Charles River Laboratories International
  • B. Braun Melsungen
  • Fresenius Kabi
  • Terumo BCT
簡介目錄

Apheresis Trends and Forecast

The future of the global apheresis market looks promising with opportunities in the blood center and hospital markets. The global apheresis market is expected to reach an estimated $2.3 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are rising prevalence of chronic renal diseases, increasing government campaigns encouraging blood donation, and expanding demand for blood components.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Apheresis by Segment

The study includes a forecast for the global apheresis by product type, method, procedure, end use, and region.

Apheresis Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Disposable and Reagents
  • Software
  • Devices

Apheresis Market by Method [Shipment Analysis by Value from 2018 to 2030]:

  • Centrifugation
  • Membrane Separation
  • Selective Adsorption

Apheresis Market by Procedure [Shipment Analysis by Value from 2018 to 2030]:

  • Donor/Automated Apheresis
  • Therapeutic Apheresis

Apheresis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Blood Centers
  • Hospitals
  • Others

Apheresis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Apheresis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies apheresis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the apheresis companies profiled in this report include-

  • Kawasumi Laboratories
  • Nikkiso
  • Haemonetics Corporation
  • Asahi Kasei Medical
  • Cerus Corporation
  • Kaneka Corporation
  • Charles River Laboratories International
  • B. Braun Melsungen
  • Fresenius Kabi
  • Terumo BCT

Apheresis Market Insights

Lucintel forecasts that centrifugation will remain the largest segment over the forecast period due to its widespread adoption in the preparation of blood components, including fresh frozen plasma and packed red blood cells.

Within this market, blood center will remain larger segment over the forecast period.

North America will remain the largest region over the forecast period due to rising adoption of cutting-edge apheresis systems and growth in the incidence of blood-related illnesses among population in the region.

Features of the Global Apheresis Market

Market Size Estimates: Apheresis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Apheresis market size by various segments, such as by product type, method, procedure, end use, and region in terms of value ($B).

Regional Analysis: Apheresis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, methods, procedures, end uses, and regions for the apheresis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the apheresis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the apheresis market size?

Answer: The global apheresis market is expected to reach an estimated $2.3 billion by 2030.

Q2. What is the growth forecast for apheresis market?

Answer: The global apheresis market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the apheresis market?

Answer: The major drivers for this market are rising prevalence of chronic renal diseases, increasing government campaigns encouraging blood donation, and expanding demand for blood components.

Q4. What are the major segments for apheresis market?

Answer: The future of the apheresis market looks promising with opportunities in the blood center and hospital markets.

Q5. Who are the key apheresis market companies?

Answer: Some of the key apheresis companies are as follows:

  • Kawasumi Laboratories
  • Nikkiso
  • Haemonetics Corporation
  • Asahi Kasei Medical
  • Cerus Corporation
  • Kaneka Corporation
  • Charles River Laboratories International
  • B. Braun Melsungen
  • Fresenius Kabi
  • Terumo BCT

Q6. Which apheresis market segment will be the largest in future?

Answer: Lucintel forecasts that centrifugation will remain the largest segment over the forecast period due to its widespread adoption in the preparation of blood components, including fresh frozen plasma and packed red blood cells.

Q7. In apheresis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising adoption of cutting-edge apheresis systems and growth in the incidence of blood-related illnesses among population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the apheresis market by product type (disposable and reagents, software, and devices), method (centrifugation, membrane separation, and selective adsorption), procedure (donor/automated apheresis and therapeutic apheresis), end use (blood centers, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Apheresis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Apheresis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Apheresis Market by Product Type
    • 3.3.1: Disposable and Reagents
    • 3.3.2: Software
    • 3.3.3: Devices
  • 3.4: Global Apheresis Market by Method
    • 3.4.1: Centrifugation
    • 3.4.2: Membrane Separation
    • 3.4.3: Selective Adsorption
  • 3.5: Global Apheresis Market by Procedure
    • 3.5.1: Donor/Automated Apheresis
    • 3.5.2: Therapeutic Apheresis
  • 3.6: Global Apheresis Market by End Use
    • 3.6.1: Blood Centers
    • 3.6.2: Hospitals
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Apheresis Market by Region
  • 4.2: North American Apheresis Market
    • 4.2.1: North American Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
    • 4.2.2: North American Apheresis Market by End Use: Blood Centers, Hospitals, and Others
  • 4.3: European Apheresis Market
    • 4.3.1: European Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
    • 4.3.2: European Apheresis Market by End Use: Blood Centers, Hospitals, and Others
  • 4.4: APAC Apheresis Market
    • 4.4.1: APAC Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
    • 4.4.2: APAC Apheresis Market by End Use: Blood Centers, Hospitals, and Others
  • 4.5: ROW Apheresis Market
    • 4.5.1: ROW Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
    • 4.5.2: ROW Apheresis Market by End Use: Blood Centers, Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Apheresis Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Apheresis Market by Method
    • 6.1.3: Growth Opportunities for the Global Apheresis Market by Procedure
    • 6.1.4: Growth Opportunities for the Global Apheresis Market by End Use
    • 6.1.5: Growth Opportunities for the Global Apheresis Market by Region
  • 6.2: Emerging Trends in the Global Apheresis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Apheresis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Apheresis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Kawasumi Laboratories
  • 7.2: Nikkiso
  • 7.3: Haemonetics Corporation
  • 7.4: Asahi Kasei Medical
  • 7.5: Cerus Corporation
  • 7.6: Kaneka Corporation
  • 7.7: Charles River Laboratories International
  • 7.8: B. Braun Melsungen
  • 7.9: Fresenius Kabi
  • 7.10: Terumo BCT